Therapies in development. Overview by Kevin McFarthing.

Kevin McFarthing: “I was diagnosed with Parkinson’s in 2012.  As a scientist, I tried to find out as much as I could about the condition.  Part of that was to investigate potential therapies that may be of benefit in the future.  This resulted in an ad ho list that needed organising in a spreadsheet.  Following lots of […]

Read More

Interview with Neurodegeneration Specialist Prof. Patrik Brundin

The following first appeared on tmrwedition. Prof. Patrik Brundin leads the Center for Neurodegenerative Science at Van Andel Research Institute where his research team is focused on experimental models and novel therapies in Parkinson’s disease. Dr. Brundin is one of the most cited scientists in neurodegenerative diseases, with a focus on Parkinson’s, and has received numerous […]

Read More